Atlas Trials

A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Patients With Pulmonary Hypertension After Cardiopulmonary Bypass Surgery

Clinical trial NCT05699486 · UNKNOWN

Trial details

NCT number
NCT05699486
Sponsor
Attgeno AB
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Pulmonary Hypertension
Start date
2022-10-23
Primary completion
2023-12-31
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.